Quicksilver Biosciences is a venture capital backed biotech startup based in NYC, specializing in the development of a versatile CMOS-integrated biosensor platform for rapid genomic identification. With a focus on achieving target sensitivities exceeding current state-of-the-art, Quicksilver aims to deliver portable and cost-effective solutions, utilizing proprietary sensing techniques.
Supported by grants from the National Institutes of Health and the National Science Foundation, Quicksilver Biosciences conducts research and technology development in stealth mode, while maintaining a publicly available conflict of interest policy.
Generated from the website